Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hepatitis b/albumine
Le lien est enregistré dans le presse-papiers
13 résultats
Method for preparation of human serum albumin-sensitized sheep erythrocytes (HSA-cell) for detection of pre-S2 antigen
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Pre-S.sub.2 Antigen protein can express polymerized human serum albumin binding activity (PHSA-BA). (A. Machida et al. A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee
Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The invention relates to a complex comprised of an insoluble polymer carrier to which human albumin is covalently bound and of a pre-S hepatitis B surface antigen (pre-S-HBsAg) as well as to a method for the purification of pre-S-HBsAg.
From EP-A2-0 243 103, a method of purifying pre-S-HBsAg is
Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The invention relates to a complex comprised of an insoluble polymer carrier to which human albumin is covalently bound and of a pre-S hepatitis B surface antigen (pre-S-HBsAg) as well as to a method for the purification of pre-S-HBsAg.
From EP-A2-0 243 103, a method of purifying pre-S-HBsAg is
Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The invention relates to a complex comprised of an insoluble polymer carrier to which human albumin is covalently bound and of a pre-S hepatitis B surface antigen (pre-S-HBsAg) as well as to a method for the purification of pre-S-HBsAg.
From EP-A2-0 243 103, a method of purifying pre-S-HBsAg is
DNA sequence encoding modified hepatitis B virus surface antigen P31 protein
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF INDUSTRIAL UTILITY
This invention relates to novel proteins useful as vaccines and a method of producing the same.
BACKGROUND ART
Type B hepatitis is a viral disease which occurs frequently in particular in the tropics of Africa, in Southeast Asia and in the Far East. Hepatitis B is
Modified hepatitis B virus surface antigen P31 and production thereof
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF INDUSTRIAL UTILITY
This invention relates to novel proteins useful as vaccines and a method of producing the same.
BACKGROUND ART
Type B hepatitis is a viral disease which occurs frequently in particular in the tropics of Africa, in Southeast Asia and in the Far East. Hepatitis B is
Hepatitis B vaccine
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The present invention relates to hepatitis B vaccine.
On a world-wide scale, the infection with hepatitis B virus (HBV) represents one of the major problems in public health care. There are an estimated 200 million persons who are carriers of HBV. These carriers are mostly asymptomatic, that is,
Isolation and purification pre-S2 containing hepatitis B virus surface antigen by chemical affinity chromatography
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
The invention relates to a method for isolating and purifying pre-S2 containing hepatitis B virus surface antigen (HBsAg) from the plasma of a carrier of HBsAg characterized by the use of polymerized human serum albumin (pHSA)-affinity column chromatography, comprising the
Devices and methods comprising an HBcAg from hepatitis B virus
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
TECHNICAL FIELD
The present invention relates generally to the antigen HBcAg from hepatitis B virus (HBV) complexed to a second protein, antibodies against such a complexed HBcAg, and to methods and compositions for the detection of such a complexed HBcAg. The methods and compositions are also
Natural pharmaceutical preparations for increasing albumin
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE PRESENT INVENTION
1. Field of Invention
The subject invention relates generally to a series of natural pharmaceutical preparations which can treat hypoproteinemia for increasing albumin. The preparations could be used to treat hypoproteinemia caused by hepatitis virus, human
Vectors for transforming CHO cells
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The invention concerns a composition useful for the fabrication of vaccines, containing or formed by approximately spherical polypeptide particles, at least as concerns most of them, these particles having immunogenic and immunologic properties characteristic of the surface antigen of the virus of
Composition useful for the fabrication of vaccines
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The invention concerns a composition useful for the fabrication of vaccines, containing or formed by approximately spherical polypeptide particles, at least as concerns most of them, these particles having immunogenic and immunologic properties characteristic of the surface antigen of the virus of
Propagation of human hepatocytes in non-human animals
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
1. INTRODUCTION
The present invention relates to the propagation of human hepatocytes in the livers of non-human animals that have been tolerized to the human cells. Such animals provide an in vivo model system of the human liver that may be used in toxicology assays and in the study of human liver
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
